Financials
Financial year 2025
LES PHARMACIES LAMBRECHTS from Sint-Jans-Molenbeek, company number BE0448543638, closed financial year 2025 with a result of € 270,032 after tax. For that financial year LES PHARMACIES LAMBRECHTS recorded a gross margin of € 513,090 and equity of € 469,117. Compared with financial year 2024, the result moved from € 219,109 to € 270,032. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.
€ 469,117
▲ 45% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 270,032
▲ 23% vs 2024
Profit after tax over the fiscal year.
€ 339,422
▲ 34% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 125,000 paid out
46 % of the profit went to the shareholders, mostly to LYRIK (100 % of the shares). That is where the money ends up.
People and assets in 2025
2.7
▼ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 179,792
▼ 1% vs 2024
€ 66,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 21,513
▲ 13% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 12,460
Loans from banks and other lenders, long and short.
€ 218,960
▼ 18% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 43,499
▲ 49% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 219,283 | € 269,743 | € 432,285 | € 513,090 | ▲ 19% |
| Profit after taxes | € 54,249 | € 102,324 | € 219,109 | € 270,032 | ▲ 23% |
| Equity | € 221,652 | € 263,976 | € 324,085 | € 469,117 | ▲ 45% |
| Total debts | € 164,745 | € 329,234 | € 485,708 | € 427,608 | ▼ 12% |
| Cash | € 170,541 | € 365,527 | € 253,737 | € 339,422 | ▲ 34% |
| Retained profit | € 148,771 | € 191,096 | € 251,204 | € 396,236 | ▲ 58% |
| Dividend | € 54,249 | € 60,000 | € 159,000 | € 125,000 | ▼ 21% |
| Bank debt | € 3,333 | € 3,256 | € 0 | € 12,460 | |
| Balance sheet total | € 386,397 | € 593,210 | € 809,793 | € 896,725 | ▲ 11% |
| Employees (FTE) | - | 2.8 | 2.8 | 2.7 | ▼ 0.1 |
Key figures of LES PHARMACIES LAMBRECHTS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to LES PHARMACIES LAMBRECHTS?
What happened at LES PHARMACIES LAMBRECHTS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 270,032 (▲ 23% vs 2024). Source: NBB ↗
- LYRIK SRL became a director. NBB
- New establishment in Sint-Jans-Molenbeek. KBO
- New establishment in Sint-Jans-Molenbeek. KBO
- Start of the company according to the CBE. KBO
In short
From € 54,249 profit in 2022 to € 270,032 profit in 2025.
Paid € 105,975 in corporate taxes since 2022.
Best year ever: 2025, with € 270,032 profit.
On average € 190,000 of value added per employee in 2025.
A new publication or filing at LES PHARMACIES LAMBRECHTS? We notify you, reason included.
Follow LES PHARMACIES LAMBRECHTSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of LYRIK comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
LES PHARMACIES LAMBRECHTSBehind LES PHARMACIES LAMBRECHTS is LYRIK SRL. The shares are held by LYRIK (100%).
Establishments
Establishment units
Physical locations of this company
Zwarte Vijversstraat 1A
1080 Sint-Jans-Molenbeek
Zwarte Vijversstraat 1 A
1080 Sint-Jans-Molenbeek
Active since 4 December 1992
Vanderdussenstraat 78
1080 Sint-Jans-Molenbeek
Active since 4 December 1992
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0448.543.638
- VAT number
- BE 0448.543.638
- Registered office
- Zwarte Vijversstraat 1A, 1080 Sint-Jans-Molenbeek
- Names & denominations
- LES PHARMACIES LAMBRECHTS
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 10 October 1992
- Peppol
- Active · Active since 27 Jul 2025
- Activities · NACE
Apothekers
Detailhandel in farmaceutische producten
Detailhandel in cosmetica en toiletartikelen